These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 19533207)
1. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX. Adler RA; Hastings FW; Petkov VI Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207 [TBL] [Abstract][Full Text] [Related]
2. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy. James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229 [TBL] [Abstract][Full Text] [Related]
3. Preoperative bone health assessment and optimization in spine surgery. Anderson PA; Kadri A; Hare KJ; Binkley N Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of using non-hip bone density inputs with FRAX®. Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA; Osteoporos Int; 2012 Mar; 23(3):853-60. PubMed ID: 22008881 [TBL] [Abstract][Full Text] [Related]
5. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients. Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045 [TBL] [Abstract][Full Text] [Related]
6. Management of osteoporosis in men on androgen deprivation therapy. Adler RA Maturitas; 2011 Feb; 68(2):143-7. PubMed ID: 21129866 [TBL] [Abstract][Full Text] [Related]
7. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer. Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269 [TBL] [Abstract][Full Text] [Related]
8. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX. Kälvesten J; Lui LY; Brismar T; Cummings S Bone; 2016 May; 86():30-5. PubMed ID: 26921822 [TBL] [Abstract][Full Text] [Related]
9. Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D. Alibhai SM; Mohamedali HZ; Gulamhusein H; Panju AH; Breunis H; Timilshina N; Fleshner N; Krahn MD; Naglie G; Tannock IF; Tomlinson G; Warde P; Duff Canning S; Cheung AM Osteoporos Int; 2013 Oct; 24(10):2571-9. PubMed ID: 23563932 [TBL] [Abstract][Full Text] [Related]
10. Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management? Sharqawi A; Hewitt K; Alexander C; El-Sakka AI; Lee L Arch Osteoporos; 2022 Nov; 17(1):143. PubMed ID: 36376762 [TBL] [Abstract][Full Text] [Related]
11. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A; Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937 [TBL] [Abstract][Full Text] [Related]
12. FRAX- vs. T-score-based intervention thresholds for osteoporosis. Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072 [TBL] [Abstract][Full Text] [Related]
13. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260 [TBL] [Abstract][Full Text] [Related]
14. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490 [TBL] [Abstract][Full Text] [Related]
15. Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study. Ye C; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Leslie WD J Bone Miner Res; 2023 May; 38(5):659-664. PubMed ID: 36807916 [TBL] [Abstract][Full Text] [Related]
16. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey. Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451 [TBL] [Abstract][Full Text] [Related]
17. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV. Vizcarra P; Gallego J; Vivancos MJ; Sifuentes WA; Llop M; Casado JL HIV Res Clin Pract; 2020; 21(2-3):63-71. PubMed ID: 32698706 [TBL] [Abstract][Full Text] [Related]
20. Trabecular bone score may improve FRAX® prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study. Iki M; Fujita Y; Tamaki J; Kouda K; Yura A; Sato Y; Moon JS; Winzenrieth R; Okamoto N; Kurumatani N Osteoporos Int; 2015 Jun; 26(6):1841-8. PubMed ID: 25752623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]